Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present TG Therapeutics, Inc. (NASDAQ: TGTX).

Full DD Report for TGTX

You must become a subscriber to view this report.


Recent News from (NASDAQ: TGTX)

TG Therapeutics, Inc. Announces Oral Presentation of Follow-Up Data from the Triple Combination of Ublituximab, Umbralisib, and Pembrolizumab in Patients with Relapsed/Refractory CLL and Richter's Transformation at 60th American Society of Hematology Annu
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced updated clinical data from its Phase I/II trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti-CD20 monoclonal antibody in combination with umbralisib (TGR-1202), the...
Source: GlobeNewswire
Date: December, 03 2018 07:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acadia, TG Therapeutics, Namaste, and Huazhu Group and Encourages Investors to Contact the Firm
NEW YORK, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Acadia Healthcare Company, Inc., TG Therapeutics, Inc., Namaste Technologies Inc., and Huazhu Group Limited.  Stockh...
Source: GlobeNewswire
Date: December, 02 2018 15:00
DEADLINE MONDAY: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ACHC and ADNT
NEW YORK, Dec. 02, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plainti...
Source: GlobeNewswire
Date: December, 02 2018 11:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
NEW YORK, NY / ACCESSWIRE / November 7, 2018 / Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (''TG'' or the ''Company'') (NASDAQ: TGTX) Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. T...
Source: ACCESSWIRE IA
Date: November, 07 2018 18:45
TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2018 Financial Results and Business Update
Investor Conference Call to be held, Friday, November 9, 2018 at 8:30 AM ET NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Friday, November 9, 2018 at 8:30 AM ET to discuss results for the third quar...
Source: GlobeNewswire
Date: November, 07 2018 07:30
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, TGTX, HAS, ADNT and GOOG
NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plainti...
Source: GlobeNewswire
Date: November, 06 2018 16:10
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
LOSANGELES, CA / ACCESSWIRE / November 6, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against TG Therapeutics, Inc. ("TG Therapeutics" or "the Company") (NASDAQ: TGTX ) for violations of §§10(b) and 20...
Source: ACCESSWIRE IA
Date: November, 06 2018 15:35
Lawsuit for Investors in shares of TG Therapeutics, Inc. (NASDAQ: TGTX) announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / November 6, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of TG Therapeutics, Inc. (NASDAQ: TGTX). The plaintiff seeks to recover losses for certain investors who purchased TG Therapeutics, Inc. (NASD...
Source: ACCESSWIRE IA
Date: November, 06 2018 08:15
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TG Therapeutics, Inc. - TGTX
NEW YORK, NY / ACCESSWIRE / November 5, 2018 / Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG" or the "Company") (NASDAQ: TGTX) Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The i...
Source: ACCESSWIRE IA
Date: November, 05 2018 18:05
SHAREHOLDER ALERT: TRCO MCHP TGTX HAS ADNT TRVN HTHT SFIX HON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaint...
Source: GlobeNewswire
Date: November, 05 2018 17:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1411.1010.9511.2510.801,328,939
2017-03-1011.9012.27512.6011.852,030,515
2017-03-0910.5511.8012.0010.2511,696,315
2017-03-0810.9010.1511.199.854,419,418
2017-03-0710.5010.9011.609.8511,196,686

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-14139,029246,33456.4392Short
2018-12-13176,639439,94840.1500Short
2018-12-1232,515129,62525.0839Cover
2018-12-1157,722115,03550.1778Short
2018-12-10128,261250,31351.2402Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TGTX.


About TG Therapeutics, Inc. (NASDAQ: TGTX)

Logo for TG Therapeutics, Inc. (NASDAQ: TGTX)

Not available

 

 

 

Current Management

  • Sean A. Power / CFO, Treasurer, Secretary
  • Michelle Carroll / VP, Corp. Dev.
  • Jenna Bosco / IR

Current Share Structure

  • Market Cap: $1,096,042,074 - 05/18/2018
  • Issue and Outstanding: 78,010,112 - 05/01/2018

 


Recent Filings from (NASDAQ: TGTX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: July, 23 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 11 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: July, 09 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: June, 25 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 18 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: June, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018

 

 


Daily Technical Chart for (NASDAQ: TGTX)

Daily Technical Chart for (NASDAQ: TGTX)


Stay tuned for daily updates and more on (NASDAQ: TGTX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: TGTX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TGTX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TGTX and does not buy, sell, or trade any shares of TGTX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/